Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference
In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration
AETIONOMY
Describing the Alzheimer’s disease data landscape: AETIONOMY researchers publish an article in Alzheimer’s & Dementia – Translational Research and Clinical Interventions
Longitudinal cohort studies are of particular value for research on progressive, neurodegenerative diseases like Alzheimer’s
EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge
On November 3rd, the European Federation of Pharmaceutical Industries and Associations (EFPIA) published a blog
Fraunhofer SCAI launches a new COVID-19 knowledge space, building on tools developed during the AETIONOMY & PHAGO projects
On 23 April, Fraunhofer SCAI launched a new COVID-19 knowledge space which hosts tools for
FRAUNHOFER repurposes technologies from the AETIONOMY project to fight SARS-CoV-2
In the course of the AETIONOMY project, Martin Hofmann-Apitius (Fraunhofer SCAI) and partners developed new
Spotlight on early-career investigators: a Neuronet interview with Alpha Tom Kodamullil
The neurodegeneration projects supported by Neuronet cover an incredibly broad research spectrum, from laboratory-based research
AETIONOMY project finalises sustainability agreement for knowledge base, data and sample sharing
The AETIONOMY project (Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development
AETIONOMY results presented to Innovative Medicines Initative leadership
AETIONOMY started five years ago exploring the idea that conventional disease definition is an increasingly outdated concept in the medical environment.
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second